医学
高钾血症
内科学
优势比
安慰剂
螺内酯
肾脏疾病
盐皮质激素受体
低风险
置信区间
危险系数
入射(几何)
内分泌学
泌尿科
醛固酮
病理
替代医学
物理
光学
作者
Xiaoling Luo,Jing Xu,Shoulian Zhou,Cheng Xue,Zewei Chen,Zhiguo Mao
标识
DOI:10.2215/cjn.0000000000000205
摘要
Among the therapeutic drugs with the potential risk of increasing serum potassium in patients with diabetic kidney disease, MRA added an extra risk of hyperkalemia while SGLT2i had the opposite effect and could even reverse the elevation of serum potassium caused by the combined regimen, including MRAs.
科研通智能强力驱动
Strongly Powered by AbleSci AI